UPMC and Chinese conglomerate Wanda Group have broken ground on the first of what is expected to be a network of hospitals in cities across China.

The hospital is being built in Chengdu, a city with a population of more than 18 million people, and it’s expected to open in 2022. Wanda will finance the planned hospitals and UPMC will co-manage the facilities, train doctors and hire staff in what UPMC calls the “biggest venture of its kind” in China by an American style academic medical center.

“This is a really big deal for Western Pennsylvania,” said Chuck Bogosta, president of UPMC’s International Services Division. “The revenue comes back to Pittsburgh.”

Wanda, best known for its signature Wanda Plazas, massive shopping complexes with movie theaters, office towers, hotels and apartments, and hospital giant UPMC are taking advantage of a shift in Chinese government policy in 2016 that prioritized improvements to the country’s health care system.

Advertise with us

Despite tense trade talks between the U.S. and China, Massachusetts General Hospital, Johns Hopkins Medicine and Washington University School of Medicine have entered the China market in recent years — drawn by the country’s aging population of 1.4 billion, which is potentially the largest health care market in the world.

“China and the U.S. have been cooperating closely in health policies, clinical medicine, personnel exchanges, public health and other fields in recent years and yielded effective results,” Nie Jiangang, deputy chief of the International Cooperation Department of China’s National Health and Family Planning Commission, told the China Daily in 2017.

But Mr. Bogosta said UPMC’s foray into China with Wanda — a 20-year deal inked last year after eight months of talks — was fundamentally different from others in that UPMC role is much broader than simply consulting.

“Our priority is that patients don’t have to leave their country or region for care,” he said. Other U.S. academic medical center in China want to attract patients to their flagship hospitals, he said. Moreover, Mr. Bogosta said that the Chinese had exempted cancer treatment equipment manufactured by Palo Alto, Calif.-based Varian Medical Systems Inc. from tariffs.

UPMC uses Varian radiation oncology equipment in its hospitals.

Advertise with us

In a prepared statement, Wanda Group Chairman Wang Jianlin said, “It’s particularly fitting that my birthplace should be the starting point for Wanda’s investment into the health and wellbeing of China’s citizens and for this visionary effort with UPMC.”

But UPMC’s international ventures are not without risk: A deal in 2009 to develop a 100-bed hospital in Cyprus with Paphos Plantations Ltd. collapsed when Paphos was unable to secure financing.

And an April story in the South China Morning Post reported that Wanda has been on a watch list by Chinese regulators since April 2017 for “highly leveraged acquisitions around the world.” The watch list was part of a government initiative to prevent private sector debt from hurting China’s financial system.

Still, Wanda Group Chairman Wang Jianlin’s net worth was estimated at $20.2 billion, according to the article. He has also defended the conglomerate’s creditworthiness.

Wanda consulted with many other academic medical centers before approaching UPMC about a partnership, Mr. Bogosta said. It didn’t take long for UPMC to accept the Chinese developer’s solicitation.

Advertise with us

“They sought us out,” he said. “We couldn’t imagine not going there.”

Kris B. Mamula: kmamula@post-gazette.com or 412-263-1699